15 It has been hypothesized that Th17 responses in chronic HBV infection may be induced by pro-inflammatory CD16+

monocytes and macrophages, which have been shown to secrete cytokines capable of promoting Th17 responses,16 possibly at least in part mediated by increased IL-6 receptor expression by CD4 T cells.17 Interestingly, a recent study has demonstrated that much of the liver damage observed in the mouse HBV transgenic model is mediated by the Th17 type cytokine IL-22, without necessarily playing a role in the non-cytolytic control of viral replication, while the concentration of IL-22 in the serum of individuals with acute HBV infection was increased.18 Th17 responses in HCV infection are less well characterized. Selleckchem Palbociclib However, given the apparent role played in multiple other immune and inflammatory conditions, they are of obvious interest. HCV-specific Th17 cells are present in chronic HCV infection.19In vitro experiments demonstrated that the HCV NS4 protein elicited IL-10 and TGF-β expression by monocytes from HCV-infected individuals, and neutralization of these cytokines Selleck Etoposide enhanced HCV-specific Th17 cell responses,

suggesting potential regulation of these responses by the virus itself.19 IL-17 producing cells have also been demonstrated in the livers of HCV chronically-infected individuals in a number of studies.20,21 Th17 cytokines have also been studied in the setting of HCV anti-viral therapy. In one study, IL-17 levels were demonstrated to be elevated in

the serum of subjects with chronic HCV infection; however, values did not correlate with viremia following 12 weeks of treatment with IFN-α and ribavirin.22 In contrast, in another study, serum Th17 type cytokines were found to be reduced after 12 weeks of HCV antiviral therapy, with the largest fall being seen in responders.23 In the setting of recurrent hepatitis C post-liver transplant, increased numbers of HCV-specific Th17 cells in the peripheral blood and increased levels 上海皓元医药股份有限公司 of serum IL-17 have been observed in individuals with more severe disease.24 In this issue of the Journal of Gastroenterology and Hepatology, Chang and colleagues have further explored IL-17 producing T cells in chronic hepatitis C virus infection.25 They demonstrated an increased proportion of IL-17 producing CD8 negative T cells in the peripheral blood of HCV chronically-infected subjects following non-specific T cell stimulation, as well as a significant increase in serum IL-17 levels in these individuals. However, serum IL-17 levels did not correlate with ALT levels or plasma HCV RNA level.